Verve Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Verve Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Verve Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Verve Therapeutics by Deutsche Bank Aktiengesellschaft
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $369k | 26k | 13.94 |
2023-09-30 | $367k | 28k | 13.26 |
2023-06-30 | $476k | 25k | 18.75 |
2023-03-31 | $549k | 38k | 14.42 |
2022-12-31 | $500k | 26k | 19.35 |
2022-09-30 | $700k | 20k | 34.28 |
2022-06-30 | $0 | 18k | 0.00 |
2022-03-31 | $486k | 21k | 23.45 |
2021-12-31 | $379k | 10k | 38.04 |
2021-09-30 | $437k | 9.5k | 46.20 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft